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Abstract
Long-term potentiation (LTP) in the hippocampal CA1 region requires the activation of N-methyl-
D-aspartate receptors (NMDARs). Studies using genetic and pharmacological approaches have
reported inconsistent results of the requirement of NR2B-containing NMDARs in LTP in the CA1
region. Pharmacological studies showed that NR2B-containing NMDARs are not required for LTP,
while genetic studies reported that over-expression of NR2B-NMDARs enhances LTP and
hippocampus-dependent memory. Here, we provide evidence showing that the functional role of
NR2B-NMDARs in hippocampal LTP and memory depends on LTP-inducing and behavior-
conditioning protocols. Inhibition of NR2B-NMDARs with the NR2B selective antagonist ifenprodil
or Ro25-6981 suppressed LTP induced by spike-timing protocol, with no impact on LTP induced
by pairing protocol or two-train high-frequency stimulation (HFS) protocol. Inhibition of NR2B-
NMDARs did not affect the late phase LTP induced by four-train HFS. Ca2+ imaging showed that
there was difference in kinetics of intracellular Ca2+ signals induced by spiking-timing and pairing
protocols. Pre-training intra-CA1 infusion of ifenprodil or Ro25-6981 impaired the contextual fear
memory induced by five CS-US pairings, with no effect on the memory induced by one CS-US
pairing.
Introduction
N-methyl-D-aspartate receptors (NMDARs) are critical for
synaptic plasticity in the hippocampus and hippocampus-
dependent learning and memory [1-3]. NMDAR is heter-
omer. Functional NMDAR has a combination of NR1 sub-
unit and at least one of NR2 subunits (A-D). In the
hippocampus, NR2A- and NR2B are two predominant
NR2 subunits for NMDARs [4,5]. The NR2-subunit com-
positions of NMDAR, whether they are NR2A- or NR2B-
containing, determines the pharmacological and kinetic
properties of the NMDAR-mediated currents [6-8]. Stud-
ies have suggested that NR2A- vs. NR2B-NMDARs may
mediate distinct synaptic functions [9,10].
Synaptic long-term potentiation (LTP) has been
widely accepted as a synaptic mechanism for learning,
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memory and other higher-order brain functions [1,2].
LTP can be induced in brain-slice preparations by dif-
ferent induction protocols [1,11]. A recent study by
Wang's group reported that NR2A- and NR2B-
NMDARs may be differentially involved in synaptic
plasticity in the CA1 region, with LTP being mediated
by NR2A-NMDAR and LTD by NR2B-NMDAR [9].
However, the conclusion that NR2B-NMDAR is selec-
tively involved in the induction of LTD but not LTP
has been challenged by the studies using NR2A-knock-
out mice [12,13] and over-expression of NR2B-
NMDARs [14], suggesting the existence of NR2A-inde-
pendent forms of LTP. Furthermore, it should be
noted that these previous studies used different slice
preparations and, especially, different protocols to
induce LTP. It might be possible that NR2B-NMDARs
contribute differentially to LTP induced under differ-
ent conditions.
Hippocampus is an essential structure for flexible spatial
memory and contextual fear memory. For example, inac-
tivation of or lesion to the hippocampal CA1 region
results in a severe deficit in contextual fear memory
[15,16]. It is well known that NMDARs in the CA1 region
are involved not only in memory acquisition [3,17,18],
but in memory retrieval as well [19]. These previous stud-
ies used non-selective NMDAR antagonists like MK-801 to
access the contributions of hippocamopal NMDARs to
memory acquisition and retrieval. The role of NR2B-
NMDAR has been largely unclear and remains to be estab-
lished.
In the present study, we examined the effects of selective
blockade of NR2B-NMDARs on LTP induced by different
protocols including spike-timing protocol [20,21], paring
protocol and high-frequency stimulation (HFS) protocol.
We also investigated the intracellular calcium signals
under different LTP-inducting protocols. We further
addressed the impacts of intra-CA1 blockade of NR2B-
NMDARs on the acquisition and retrieval of contextual
fear memory induced by different conditioning strengths.
Materials and methods
Animals
Rats and mice were used for the present study. The ani-
mals housed in plastic cages and maintained on a 12-h
light/dark cycle. Food and water were available ad libitum
throughout the experiment. All experimental procedures
were in accordance with the Guide for the Care and Use of
Laboratory Animals issued by the National Institutes of
Health, USA (1996) and approved by the Ethical Com-
mittee of Animal Experiments at Fudan University Insti-
tute of Neurobiology (Shanghai, China) and by the
Animal Studies Committee at the University of Toronto
(Toronto, Canada).
Drugs
To address the functions of NR2B-containing NMDARs,
we used two selective antagonists: the non-competitive
NR2B antagonist ifenprodil tartrate salt (Sigma-Aldrich
Co., USA) and its derivative Ro25-6981 hydrochloride
(Tocris, UK). In LTP recording experiments, we used the 3
μM dose of ifenprodil and the 0.3, 0.5 or 3.0 μM doses of
Ro25-6981 to block NR2B-NMDARs. In behavioral exper-
iments, we locally infused the 0.2 μg dose of ifenprodil or
the 5.0 μg dose of Ro25-6981 into the CA1 region to
inhibit NR2B-NMDARs.
To dissect the functions of NR2A-containing NMDARs,
the relatively selective NR2A antagonist NVP-AAM077 (a
generous gift from Novartis Pharma, Basel, Switzerland)
was used. We selected the 0.3 μM dose of NVP-AAM077 in
LTP recording experiments to dissect NR2A-NMDAR con-
tributions, as our previous study showed that NVP-
AAM077 at the dose of 0.3 μM did not affect NR2B-
NMDAR currents in vitro [22]. For behavioral experi-
ments, we locally infused the 0.012 and 0.12 μg doses of
NVP-AAM077 into the CA1 region to block NR2A-
NMDARs. The 0.12 μg/μl dose of NVP-AAM077 is equal
to the 0.2 μg/μl dose of ifenprodil in molarity.
Whole-cell patch clamp recordings
Sprague-Dawley rats (male, 200–220 g, 8–10 week old)
were used for the experiments of whole-cell patch clamp
recordings. Rats were anesthetized with inhaled isoflu-
rane. Transverse hippocampal slices (300 μm in thick-
ness) were rapidly prepared. Slices were incubated at
room temperature for at least 1 h, and were then trans-
ferred to a recording chamber. The chamber was perfused
at a speed of 2 ml/min with artificial cerebrospinal fluid
(ACSF) consisting of (in mM): 124 NaCl, 2.5 KCl, 2
CaCl2, 1 MgSO4, 25 NaHCO3, 1 NaH2PO4, and 10 glu-
cose (saturated with 95% O2 and 5% CO2) and 100 μM
picrotoxin. The CA3 region was removed in order to
reduce transmission of picrotoxin-induced epileptiform
bursting to the CA1 region. Whole-cell patch clamp
recordings were made in CA1 pyramidal neurons. Tar-
geted neurons were voltage clamped at -60 mV. EPSCs
were evoked by extracellular stimulation of Schaffer col-
laterals using a bipolar stimulating electrode at a rate of
0.02 Hz. The stimulating electrode was placed at about
100 μm distant from the cell body.
Spike-timing and pairing protocols were used to induce
LTP in patched cells. In spike-timing protocol, three pres-
ynaptic stimuli at 30 Hz, which caused three EPSPs, were
paired with three postsynaptic action potentials (APs),
and did so 15 times with an interval of 5 s. Presynaptic
stimulus was delivered 10 ms before postsynaptic AP. The
recording pipette (3–5 MΩ) was filled with solution con-
taining (in mM): 145 K-gluconate, 5 NaCl, 1 MgCl2, 0.2Molecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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EGTA, 10 HEPES, 2 Mg-ATP, and 0.1 Na3-GTP (adjusted
to pH 7.2 with KOH). In pairing protocol, a train of 200
stimulation pulses (at 2 Hz) were delivered presynapti-
cally, paired with a depolarization (to -5.0 mV) of postsy-
naptic cell (patched cell). The recording pipette (3–5 MΩ)
was filled with solution containing (in mM): 102 Cs-glu-
conate, 3.7 NaCl, 11 BAPTA, 0.2 EGTA, 20 HEPES, 2 Mg-
ATP, 0.3 Na3-GTP and 5 QX-314 (adjusted to pH 7.2 with
CsOH). After EPSC recording was stable for 10 min, spike-
timing protocol or pairing protocol was used to induce
LTP. The access resistance was 15–30 MΩ. The input resist-
ance was monitored throughout the recording experi-
ment. Data were discarded if input resistance changed by
more than 20%.
Field potential recordings
C57BL/6 mice (male, 6–8 week old) were used for the
experiments of field-potential recordings. Mice were anes-
thetized with inhaled isoflurane. Transverse slices of hip-
pocampus were rapidly prepared and maintained in an
interface chamber at 28°C, in which the slices were per-
fused with ACSF. The slices were kept in the recording
chamber for at least 2 h before the experiments. A bipolar
tungsten stimulating electrode was placed in the stratum
radiatum of the CA1 region, and extracellular field poten-
tials were recorded in the stratum radiatum, using a glass
microelectrode (3–12 MΩ, filled with ACSF). Stimulation
intensity was adjusted to produce a response with 0.5~1.0
mV amplitude. Test responses were elicited at 0.02 Hz.
Two trains of HFS (100 pulses at 100 Hz, with inter-train
interval of 20 s) were used to induce early LTP (E-LTP) and
four trains of HFS (100 pulses at 100 Hz, with inter-train
interval of 5 min) to induce late LTP (L-LTP).
Calcium Imaging
C57BL/6 mice (male, 3–4 week old) were used for the
experiments of calcium imaging. Mice were anesthetized
with inhaled isoflurane and were decapitated. Transverse
slices of hippocampus (300 μm in thickness) were pre-
pared and transferred to a submerged recovery chamber
with oxygenated (95% O2 and 5% CO2) ACSF at room
temperature. Oregon green BAPTA-1 (OGB-1, 0.4 mM;
Molecular Probes) was dialyzed into hippocampal CA1
neurons by whole-cell patch pipettes. Once patched in
whole-cell mode, the neurons were maintained for at least
10 min to allow for filling with OGB-1 before image
acquisition. Fluorescent signals were imaged by a confocal
microscope (Fluoview FV 1000, Olympus, Tokyo, Japan).
The laser with a wavelength of 488 nm was used for exci-
tation and fluorescence was recorded through a bandpass
filter (500–550 nm). The images were acquired using a
40×, 0.8 numeric aperture water-immersion objectives
every 0.5 s after a 0.188-s exposure to 488-nm light. XYT
image galleries were collected. Average fluorescence inten-
sity in the region of interests (ROI) was measured for
quantification. The ROI was around 100 μm from soma.
The intensity was expressed as F/F0, where F0 is the fluo-
rescence intensity before LTP induction.
Fear conditioning
Fear conditioning was performed in a plexiglas condition-
ing chamber with a metal grid floor (San Diego Instru-
ments, USA). Infrared equipment was located on the walls
to monitor freezing behavior of rats. Rats were given 5
min to acclimate to the chamber pre-conditioning. Two
conditioning protocols were employed. For one CS-US
pairing protocol, rats were presented with one tone (con-
ditioned stimulus, CS; 2.2 kHz and 96 dB for 30 s), which
co-terminated with a foot shock (unconditioned stimu-
lus, US; 1.0 mA, 2 s). For five CS-US pairing protocol, rats
received five CS-US pairings (1.0 mA, 0.5 s for each US),
with inter-pairing interval of 90–120 s [23]. After condi-
tioning, rats were placed back to home cages.
Memory retention was tested 48 h post-conditioning. For
testing of contextual fear memory, rats were placed into
the original chamber, where the rats had been condi-
tioned, and allowed to stay there for 3 min without tone
or footshock. Freezing response during this period was
used as a measure for contextual fear memory. For testing
of auditory fear memory, rats were placed into a novel
chamber for 90 s and were then given three CSs, each last-
ing 30 s with inter-CS interval of 20 s. Freezing response
during the CS presentations was used as a measure for
auditory fear memory.
Histology
To verify the locations of drug infusion, rats were anesthe-
tized with pentobarbital sodium (50 mg/kg, i.p.) and per-
fused transcardially with saline, followed by 4% (vol/vol)
formaldehyde solution. Rat brains were placed into 30%
(wt/vol) sucrose solution and subsequently cut into
40~50 μm sections with a cryostat (Leica CM900, Ger-
many). Brain sections were mounted on gelatin-subbed
glass slides and stained with neural red (1% in ddH2O).
Images were taken using a light microscope (Leica
DMRXA Q5001W) equipped with a CCD camera.
Data analysis
Data in the text and figures are expressed as means± SEM.
Student's t-test was used to compare LTP data. An one-way
Analysis of Variance (ANOVA) was employed to compare
behavioral data, with planned comparisons as post hoc
analysis. In all cases, p < 0.05 was considered significant.
Statistical analysis was performed using STATISTICA
(StatSoft Inc., Chicago, IL, USA).
Results
LTP induced by spike-timing protocol
To test whether the involvement of NR2B-NMDARs is
dependent on specific LTP induction paradigm, we first
examined the role of NR2B- and NR2A-NMDARs in LTPMolecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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induced by spike-timing protocol (also named EPSPs-APs
protocol) (Figure 1A). To be consistent with the experi-
mental conditions used by Wang's Group [9], we first per-
formed whole-cell patch clamp recordings in CA1
pyramidal neurons from rat hippocampus. Spike-timing
protocol caused a significant potentiation of synaptic
responses (Figure 1B: 190.8 ± 12.2% of baseline at 25–30
min post-induction, n = 8 slices; p < 0.05 vs. baseline). We
then tested the possible contribution of NR2B-NMDARs.
The non-competitive, selective NR2B-NMDAR antagonist
ifenprodil (3 μM) was perfused throughout the experi-
ments. As shown in Figure 1C and 1E, ifenprodil signifi-
cantly reduced the potentiation (121.4 ± 10.7% of
baseline, n = 8 slices, p < 0.05 vs. control). Similar inhibi-
tory effects were found with another NR2B-NMDAR
antagonist Ro25-6981 (Figure 1D and 1E: For 0.3 μM
Ro25-6981, 130.6 ± 13.1% of baseline, n = 7 slices, p <
0.05 vs. control; For 0.3 μM Ro25-6981, 116.1 ± 13.4% of
baseline, n = 8 slices, p < 0.05 vs. control).
Bath application of the NR2A relatively selective antago-
nist NVP-AAM077 (0.3 μM) also reduced LTP induced by
spike-timing protocol (Figure 1F: 108.9 ± 12.1% of base-
line, n = 7 slices, p < 0.05 vs. control). These results pro-
vide evidence that both NR2B- and NR2A-NMDARs
contribute to LTP induced by spike-timing protocol.
LTP induced by pairing protocol
Next, we examined the effect of NR2B inhibition on LTP
induced by pairing protocol (Figure 2A). Whole-cell
recordings were done in CA1 pyramidal cells. The pairing
protocol induced a significant potentiation of synaptic
responses (Figure 2B: 192.1 ± 22.0% of baseline, n = 6
slices; p < 0.05 vs. baseline). Bath application of 0.5 μM
Ro25-6981 did not affect the synaptic potentiation (Fig-
ure 2C: 181.6 ± 22.8% of baseline, n = 5 slices; p < 0.05 vs.
baseline). As shown in Figure 2D, there was no significant
difference in LTP amplitudes in the presence and absence
of Ro25-6981 (25–30 min post-induction, p > 0.05 for
Ro25-6981 vs. control). This result indicates that NR2B-
NMDARs are not required for LTP induced by the pairing
protocol in the CA1 region, consistent with the previous
report by Liu et al. [9]
LTP induced by high-frequency stimulation
We then investigated the effect of NR2B-NMDAR block-
ade on LTP induced by HFS using in vitro field-potential
recordings. A two-train HFS induced a robust and sus-
tained potentiation of synaptic responses in the CA1
region in control experiments (Figure 3B: 174.2 ± 22.5%
of baseline at 40–45 min post-HFS, p < 0.05 vs. baseline,
n = 10 slices). A similar amount of potentiation was
observed in the presence of 0.5 μM Ro25-6981 (Figure 3B:
172.3 ± 15.5% of baseline, p < 0.05 vs. baseline; p > 0.05
vs. control; n = 7 slices), indicating that LTP induced by
HFS does not involve NR2B-NMDARs.
To address the possible role of NR2B-NMDARs in L-LTP,
we used a four-train HFS to induce L-LTP in the CA1
region (Figure 4A). As shown in Figure 5B, the potentia-
tion of filed EPSP was robust and sustained for over 3 h
after the delivery of the HFS (209.6 ± 57.0% of baseline at
170–180 min post-HFS p < 0.05 vs. baseline, n = 7 slices).
Bath application of 0.5 μM Ro25-6981 did not affect the
L-LTP (Figure 4B: 200.7 ± 33.5% of baseline; p < 0.05 vs.
baseline; p > 0.05 vs. control, n = 5 slices). This result indi-
cates that NR2B-NMDARs are not required for the L-LTP.
Ca2+ signals triggered by spike-timing and pairing protocols
Calcium influx into postsynaptic neurons is a critical
event in synaptic plasticity in the CA1 region. Here, we
examined the intracellular Ca2+ signals elicited by spike-
timing and pairing protocols and evaluated the contribu-
tions of NR2B-NMDARs using calcium imaging. The two
protocols triggered an increase in [Ca2+]i with different
kinetics (Figure 5C and 5D, upper). Treatment with ifen-
prodil (3 μM) reduced the Ca2+ signals under both proto-
cols (Figure 5C and 5D, middle). By calculating the
difference of the signals in control and in the presence of
ifenprodil, we obtained the NR2B-NMDAR mediated Ca2+
signals (Figure 5C and 5D, lower). As shown, the NR2B-
NMDAR mediated calcium signal under the spike-timing
protocol was much different in kinetics but not in abso-
lute quantity from that under the pairing protocol. This
difference in kinetics of Ca2+ efflux might help explain
why NR2B-NMDARs are required for LTP induced by
spike-timing protocol but not pairing protocol. It may be
possible that the fluctuation of the NR2B-mediated Ca2+
efflux is a critical factor for induction of LTP under the
spike-timing protocol.
Acquisition of contextual fear memory
A previous study in our laboratory showed that intra-CA1
blockade of NR2B-NMDARs with Ro25-6981 (5.0 μg)
had no effect on the acquisition of contextual fear mem-
ory in both rats and mice [24]. In that study, we trained
the animals with a single CS-US pairing. Here, we re-
examined the effect of intra-CA1 blockade of NR2B-
NMDARs on the acquisition of contextual fear memory
using another selective NR2B-NMDAR antagonist ifen-
prodil. We also investigated the effect of intra-CA1 block-
ade of NR2A-NMDARs, using the relatively selective
NR2A-NMDAR antagonist NVP-AAM077.
Intra-CA1 infusion of NVP-AAM077 (0.012 μg in 1 μl
PBS, n = 6 rats; 0.12 μg in 1 μl PBS, n = 8 rats), ifenprodil
(0.2 μg in 1 μl PBS, n = 7 rats), or Ro25-6981 (5.0 μg in 1
μl PBS, n = 8 rats) was performed 15 min before the ani-
mals received the single CS-US pairing protocol. PBS wasMolecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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NR2B-NMDARs are required for LTP induced by spike-timing protocol in area CA1 Figure 1
NR2B-NMDARs are required for LTP induced by spike-timing protocol in area CA1. A. Schematic diagram of the 
spike-timing protocol. B. Spike-timing protocol, as indicated by the arrow, induced a significant LTP in CA1 pyramidal neurons 
(n = 8). Sample traces of EPSC are the averages of 7 consecutive responses recorded during 5–10 min and 25–30 min, respec-
tively. C. Bath application of ifenprodil partially blocked the LTP. n = 8 neurons D. Bath application of Ro25-6981 partially 
blocked the LTP. n = 7 neurons for 0.3 μM Ro25-6981; n = 8 neurons for 3 μM Ro25-6981. E. Histograms showing the effects 
of ifenprodil and Ro25-6981 on the LTP. *p < 0.05 vs. control. F. NR2A-NMDARs are required for LTP induced by spike-tim-
ing protocol in area CA1. Bath application of NVP-AAM077 blocked the LTP. n = 7 neurons. inset: Histogram showing the 
effect of NVP-AAM077 on the LTP. *p < 0.05 vs. control.Molecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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NR2B-NMDARs are not required for LTP induced by pairing protocol in area CA1 Figure 2
NR2B-NMDARs are not required for LTP induced by pairing protocol in area CA1. A. Schematic diagram of the 
pairing protocol. B. Pairing protocol, as indicated by the arrow, induced a significant LTP in CA1 pyramidal neurons (n = 6). 
Sample traces of EPSC are the averages of 7 consecutive responses recorded during 5–10 min and 25–30 min, respectively. C. 
Bath application of Ro25-6981 (0.5 μM) had no effect on the LTP (n = 5). D. Histogram showing the effect of Ro25-6981 on the 
LTP. p > 0.05 vs. control.Molecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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NR2B-NMDARs are not required for LTP induced by HFS protocol in area CA1 Figure 3
NR2B-NMDARs are not required for LTP induced by HFS protocol in area CA1. A. Schematic diagram of the high 
frequency stimulation (HFS; 2 train). B. LTP of field EPSP induced by the HFS in control (n = 10 slices) and in the presence of 
Ro25-6981 (n = 7 slices). Ro25-7981 had no effect on the LTP.Molecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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NR2B-NMDARs are not required for L-LTP induced by HFS protocol in area CA1 Figure 4
NR2B-NMDARs are not required for L-LTP induced by HFS protocol in area CA1. A. Schematic diagram of the 
high frequency stimulation (HFS; 4 trains). B. Late phase LTP of field EPSP induced by the HFS in control (n = 7 slices) and in 
the presence of Ro25-6981 (n = 5 slices). Ro25-7981 had no effect on the L-LTP.Molecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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NR2B-NMDAR mediated Ca2+ influx under spiking-timing and pairing protocols Figure 5
NR2B-NMDAR mediated Ca2+ influx under spiking-timing and pairing protocols. A. A representative image show-
ing the CA1 pyramidal neuron filled with OGB-1. ROI, region of interests. B. Raw sample fluorescence images from the ROI 
before (1), during (2) and after (3) induction of LTP with the spike-timing protocol. Scale bar, 1.0 μm. C. Elevation of Ca2+ sig-
nal in the ROI during induction of LTP with the spike-timing protocol (upper). Treatment with ifenprodil (3 μM) reduced the 
Ca2+ signal (middle). The difference of [Ca2+] signals in control and in the presence of ifenprodil (lower) shows the NR2B-
NMDAR mediated Ca2+ influx. D. Elevation of Ca2+ signal in the ROI during induction of LTP with the pairing protocol 
(upper). Treatment with ifenprodil (3 μM) reduced the Ca2+ signal (middle). The difference of [Ca2+] signals in control and in 
the presence of ifenprodil (lower) shows the NR2B-NMDAR mediated Ca2+ influx.Molecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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similarly infused as vehicle control (1 μl; n = 9 rats). Fear
memory was tested 48 h post-conditioning. As shown in
Figure 6A1, rats with intra-CA1 infusion of ifenprodil
demonstrated no difference in contextual freezing score in
relative to vehicle controls (F(1,14) = 0.23, p > 0.05 for
ifenprodil vs. vehicle). By contrary, rats with intra-CA1
infusion of NVP-AAM077 exhibited a severe deficit in
contextual fear memory (F(1,13) = 7.93, p  < 0.01 for
0.012 μg NVP-AAM077 vs. vehicle; F(1,15) = 6.13, p <
0.05 for 0.12 μg NVP-AAM077 vs. vehicle). Auditory fear
memory was tested 1 h after contextual fear memory was
tested. As shown in Figure 6A2, rats with intra-CA1 block-
ade of NR2B- and NR2A-NMDARs showed no deficit in
auditory fear memory (F(4,31) = 0.60, p > 0.05). Thus, the
acquisition of contextual fear memory induced by the sin-
gle CS-US pairing involves NR2A- but not NR2B-
NMDARs in the CA1 region.
Considering that the importance of NR2B-NMDARs for
LTP induction is protocol-dependent, we attempted to
know whether the role of NR2B-NMDARs in memory
acquisition is also dependent on training paradigms. To
address this, we examined the effects of intra-CA1 inhibi-
tion of NR2B- as well as NR2A-NMDARs on the acquisi-
tion of contextual fear memory induced by the five CS-US
pairing conditioning. Our pilot experiment showed that
the five CS-US pairing protocol could induce more freez-
ing responses than the single CS-US pairing protocol did
(Table 1).
Intra-CA1 injection of NVP-AAM077 (0.012 μg in 1 μl
PBS, n = 6 rats), ifenprodil (0.2 μg, n = 7 rats), or Ro25-
6981 (5.0 μg, n = 8 rats) was performed 15 min before the
animals was trained with the five CS-US pairing protocol.
PBS was similarly infused as vehicle control (1 μl, n = 7
rats). Fear memory was tested 48 h post-conditioning. As
shown in Figure 6B1, rats treated with NVP-AAM077, ifen-
prodil or Ro25-6981 showed a deficient contextual fear
memory as compared with vehicle controls (F(1, 11) =
35.3, p < 0.01 for NVP-AAM077 vs. vehicle; F(1, 12) =
31.21, p < 0.01 for ifenprodil vs. vehicle; F(1, 13) = 26.05,
p < 0.01 for Ro25-6981 vs. vehicle). However, the rats
with intra-CA1 blockade of NR2B- and NR2A-NMDARs
showed a normal auditory fear memory (Figure 6B2:
F(3,24) = 0.72, p > 0.05). Thus, both NR2A- and NR2B-
NMDARs in the CA1 region are required for the acquisi-
tion of contextual fear memory induced by the five CS-US
pairing conditioning.
Retrieval of contextual fear memory
As just described, NR2B-NMDARs in the CA1 region are
involved in the acquisition of contextual fear memory in
a conditioning-strength dependent way. Here, we wanted
to know if NR2B-NMDARs are involved in the retrieval of
contextual fear memory in a similar way.
First, we examined the effects of intra-CA1 blockade of
NR2B- as well as NR2A-NMDARs on memory retrieval for
the single CS-US pair conditioning. NVP-AAM077 (0.012
μg in 1 μl PBS, n = 6 rats; 0.12 μg in 1 μl PBS, n = 7 rats),
ifenprodil (0.2 μg in 1 μl PBS, n = 8 rats), or Ro25-6981
(5.0 μg in 1 μl PBS, n = 6 rats) was infused into the CA1
region 15 min before memory retention was tested. PBS
was similarly infused as vehicle control (1 μl, n = 9 rats).
As shown in Figure 7A1, An one-way ANOVA revealed a
significant group effect on contextual freezing scores
(F(4,31) = 8.12, p < 0.05). Planned comparison showed
that the rats treated with NVP-AAM077, ifenprodil, or
Ro25-6981 exhibited a deficient contextual fear memory
(F(1,13) = 15.48, p < 0.01 for 0.012 μg NVP-AAM077 vs.
vehicle; F(1,14) = 10.61, p  < 0.01 for 0.12 μg NVP-
AAM077 vs. vehicle; F(1,15) = 20.71, p < 0.01 for ifen-
prodil vs. vehicle; F(1, 13) = 13.23, p < 0.01 for Ro25-
6981 vs. vehicle). However, each group of rats demon-
strated a normal auditory fear memory (Figure 7A2: F(4,
21) = 0.62, p > 0.05).
Then, we examined the effects of intra-CA1 inhibition of
NR2B- as well as NR2A-NMDARs on memory retrieval for
the five CS-US pairing conditioning. NVP-AAM077
(0.012 μg in 1 μl PBS, n = 6 rats), ifenprodil (0.2 μg in 1
μl PBS, n = 6 rats), or Ro25-6981 (5.0 μg in 1 μl PBS, n =
5 rats) was infused into the CA1 region 15 min before
memory retention test. PBS was similarly injected as vehi-
cle control (1 μl, n = 7 rats). As shown in Figure 7B1, an
one-way ANOVA revealed a significant group effect on
contextual freezing scores (F(3,20) = 8.12, p  < 0.01).
Planned comparison showed that the rats treated with
NVP-AAM077, ifenprodil, or Ro25-6981 demonstrated a
deficient contextual fear memory (F(1,11) = 19.66, p <
0.01 for NVP-AAM077 vs. vehicle; F(1,11) = 12.10, p <
0.01 for ifenprodil vs. vehicle; F(1, 10) = 13.06, p < 0.01
for Ro25-6981 vs. vehicle). Auditory fear memory was
intact upon the drug infusion (Figure 7B2: F(3,16) = 0.22,
p > 0.05).
Taken together, these results strongly suggest that NR2B-
NMDARs, as well as NR2A-NMDARs, in the CA1 region
are required for the retrieval of contextual fear memory
induced by the one and five CS-US pairing protocols.
Discussion
The present study shows that NR2B-NMDARs are required
for LTP induced by the spike-timing protocol, but not for
LTP induced by the pairing or HFS protocol. Intracellular
Ca2+ signals triggered by spiking-timing and pairing pro-
tocols display different kinetics. Late-phase LTP induced
by HFS protocol does not involve NR2B-NMDARs. More-
over, the significance of NR2B-NMDARs in acquisition of
contextual fear memory is dependent on conditioning
protocols.Molecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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NR2B-NMDARs are required for the acquisition of contextual fear memory induced by the five but not one CS-US pairing  conditioning Figure 6
NR2B-NMDARs are required for the acquisition of contextual fear memory induced by the five but not one 
CS-US pairing conditioning. A. Pre-training intra-CA1 inhibition of NR2B-NMDARs had no impact on, while inhibition of 
NR2A-NMDARs impaired 48-h contextual fear memory induced by the single CS-US pairing protocol (A1). The acquisition of 
auditory fear memory was intact (A2). The result with Ro25-6981 was reported in the previous study (Zhao et al., 2005). *p < 
0.05 vs. vehicle B. Pre-training intra-CA1 inhibition of NR2B- or NR2A-NMDARs impaired 48-h contextual fear memory 
induced by the five CS-US pairing protocol (B1). The acquisition of auditory fear memory was intact (B2). **p < 0.01 vs. vehicle. 
C. Reconstruction of the infusion sites in the CA1 region. Filled squares: vehicle; Open circles: 0.012 μg NVP-AAM077; Filled 
circles: 0.12 μg NVP-AAM077; Open triangles: ifenprodil; Grey squares: Ro25-6981. D. A representative coronal section 
showing an infusion site of ifenprodil in the CA1 region.Molecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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Role of NR2B-NMDARs in LTP
Many previous studies using different experimental
approaches have shown that NR2B-NMDARs contribute
to synaptic potentiation in different areas of the central
nervous system [12-14,24-26]. However, some other stud-
ies have reported that NR2B-NMDARs are not required for
synaptic potentiation or LTP [9,10]. Considering that
NR2B- and NR2A- NMDARs have different biophysical
properties and couple to different intracellular signaling
cascades [8,26-29], it may be possible that different induc-
tion protocols may activate different NMDAR subtypes.
Indeed, it has been reported that different LTP-inducing
protocols recruit different signaling pathways. For exam-
ple, in the amygdala, pairing-protocol induced LTP
depends on L-type voltage-gated calcium channels (L-
VGCCs) but not NMDARs, while tetanus-stimulation
induced LTP involves NMDARs but not L-VGCCs [30]. In
the present study, we demonstrate that the involvement of
NR2B-NMDARs in LTP is dependent on induction proto-
cols. NR2B-NMDARs are required for LTP induced by the
spike-timing protocol, but not by the pairing protocol.
Although it has been reported that a low dose Ro25-6981
(0.3 μM) enhances, but not reduces NMDAR-mediated
EPSCs in the CA1 region [24,31], the same dose Ro25-
6981 in the present study reduced LTP induced by the
spike timing protocol, but not by the pairing protocol
(Table 2).
The induction of spike timing-dependent LTP requires
activation of NMDAR [20,21]. Spike timing-dependent
potentiation requires the temporal window between pre-
synaptic spikes and postsynaptic EPSPs. It is known that
NR2B- and NR2A-NMDARs have different characteristics:
NR2B-NMDARs have slower kinetics than NR2A-
NMDARs [27]. It is possible that NR2B-NMDARs are
more sensitive to the certain form of LTP induction proto-
col. Berberich et al. reported that the amount of charge
transfer during LTP induction is a critical factor in low-fre-
quency stimulation pairing [31]. Thus, there is such a pos-
sibility, although remains to be demosntrated, that
inhibition of NR2B-NMDARs affect the charge transfer
during LTP induction.
The induction-protocol dependent involvement of NR2B-
NMDARs in LTP suggests that LTP induced by different
protocols may have different intracellular mechanisms.
Indeed, it has been suggested that different LTP induction
protocols may activate distinct signaling cascades that
generate LTP with different expression mechanisms [32-
34]. LTP induction in the CA1 region requires Ca2+ influx
through NMDAR, either through direct activation of Ca2+-
sensitive substrates and/or subsequent Ca2+ release from
intracellular Ca2+ stores [1,35]. Ca2+ influx activates cal-
cium/calmodulin-dependent protein kinase II (CaMKII),
which is required as a critical cellular cascades for NMDA-
dependent LTP [11,36]. Recently, Gerkin et al. reported
that NMDAR subtypes can differentially activate competi-
tive signaling modules in the induction and integration of
spike-timing-dependent plasticity [37]. That is, Ca2+
influx via NR2B-NMDARs may activate either CaMKII or
calcineurin (CaN), which is dependent on the outcome of
dynamic competition driven by NMDA receptor subtypes.
Our data suggested that Ca2+ influx via NR2B-NMDARs
induced by spike-timing protocol can activate CaMKII
and lead to LTP. Furthermore, our calcium imaging in the
present study showed that the NR2B-NMDAR mediated
Ca2+ transients were faster under the spike-timing than
pairing protocols, which might explain the different sig-
nificance of NR2B-NMDARs in LTP under the two proto-
cols since fast Ca2+ transients are better for LTP, but slow
Ca2+ transients not [38].
Role of NR2B-NMDARs in memory
It has been documented that NR2B-NMDARs in the hip-
pocampus, amygdala and anterior cingulate cortex play
an important role in memory or persistent pain
[14,24,39,40]. Genetic over-expression of NR2B receptor
subtype in the forebrain enhances spatial memory as well
as contextual fear memory [14], whereas pharmacological
blockade of NMDARs in the CA1 region impairs contex-
tual fear memory [19]. Pharmacological blockade of
NR2B-NMDARs in the lateral amygdala or in the ACC
impairs formation of fear memory [23,24]. However, it is
unclear whether hippocampal NR2A- and NR2B-
NMDARs have differential roles in fear memory forma-
tion.
The present study shows that, unlike NR2A-NMDARs that
are required non-differentially, NR2B-NMDARs are
involved in acquisition of contextual fear memory in a
conditioning-strength dependent way. Pre-conditioning
intra-CA1 infusion of the NR2B selective antagonist ifen-
prodil or Ro25-6981 impaired contextual fear memory
induced by five but not one CS-US pairing protocol, while
Table 1: Contextual fear memory induced by the one and five CS-US pairing protocols
Protocol Pre-shock 48-h Retention Test
Protocol 1: 1 CS-US (US: 1.0 mA, 2.0 s) 11.27 ± 4.65 72.86 ± 3.20
Protocol 2: 5 CS-US (US: 1.0 mA, 0.5 s) 9.53 ± 2.05 90.00 ± 1.77 **
Data is expressed as the percentage of freezing (mean ± SEM). Protocol-1: n = 7; Protocol-2: n = 6. **p < 0.01 vs. Protocol 1, t-test.Molecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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NR2B-NMDARs are required for the retrieval of contextual fear memory induced by both five and one CS-US pairing condi- tioning Figure 7
NR2B-NMDARs are required for the retrieval of contextual fear memory induced by both five and one CS-US 
pairing conditioning. A. Pre-retrieval intra-CA1 inhibition of NR2B- or NR2A-NMDARs impaired the expression of 48-h 
contextual fear memory induced by the single CS-US pairing protocol (A1). The expression of 48-h auditory fear memory was 
intact (A2). **p < 0.01 vs. vehicle. B. Pre-retrieval intra-CA1 inhibition of NR2B- or NR2A-NMDARs impaired the expression 
of 48-h contextual fear memory induced by the five CS-US pairing protocol (B1). The expression of 48-h auditory fear memory 
was intact (B2). **p < 0.01 vs. vehicle. C. Reconstruction of the infusion sites in the CA1 region. Filled squares: vehicle; Filled 
circles: NVP-AAM077; Open triangles: ifenprodil; Open circles: Ro25-6981. D. A representative coronal section showing an 
infusion site of ifenprodil in the CA1 region.Molecular Brain 2008, 1:9 http://www.molecularbrain.com/content/1/1/9
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similar treatment with the NR2A antagonist NVP-
AAM077 disrupted memory for both protocols. This is
well consistent with a recent study in our laboratory [41],
showing that NR2B-NMDARs in the basolateral nucleus
of amygdala (BLA) are involved in acquisition of auditory
fear memory also in a conditioning-strength dependent
way. In that study, we reported that pre-conditioning
intra-BLA infusion of the NR2B selective antagonist ifen-
prodil or Ro25-6981 impaired auditory fear memory
induced by five but not one CS-US pairing protocol, while
similar treatment with the NR2A antagonist NVP-
AAM077 interfered with memory for both protocols.
Consistently, genetic over-expression of NR2B C-terminal
in the BLA, which interferes with the C-terminal mediated
intracellular signaling, produced a severe deficit in audi-
tory fear memory for five but not one CS-US pairing pro-
tocol, whereas over-expression of NR2A C-terminal
produced a deficient memory for both protocols. There
seems a recruitment mechanism in the hippocampus and
amygdala for involvement of NR2B-NMDARs in memory
acquisition: the heavier the training load is, the more
involved the NR2B-NMDAR is.
Selectivity of NVP-AAM077
NR2A- and NR2B-NMDARs have distinct electrophysio-
logical and signaling properties [8,27,42-48]. Dissection
of the functions of NR2A- and NR2B-NMDARs will pro-
mote our understanding of their roles in learning and
memory. As specific antagonists for NR2A-NMDAR are
not available, the role of NR2A-NMDARs in learning and
memory is still poorly understood. Recently, a relatively
selective NR2A-NMDAR antagonist, NVP-AAM077, has
been developed. However, some previous studies argue
that NVP-AAM077 is not sufficient to discriminate
between NR2A- and NR2B-NMDARs, with about 10-fold
higher selectivity for NR2A- than for NR2B-NMDARs
[49,50].
In the present study, we used NVP-AAM077 (0.012 or
0.12 μg in 1.0 μl vehicle) for pharmacological blockade of
NR2A-NMDARs in the CA1 region. We found that treat-
ment with NVP-AAM077 non-differentially impaired the
acquisition of fear memory induced by the two condition-
ing protocols, one of which included a single CS-US pair-
ing and the other five CS-US pairings. Although NVP-
AAM077 could act at NR2B as well, it is unlikely that the
NVP-AAM077 effect was mediated by NR2B-NMDARs,
because similar treatment with the selective NR2B-
NMDAR antagonist ifenprodil (0.2 μg in 1.0 μl vehicle,
equal molarity with 0.12 μg/1.0  μl NVP-AAM077) or
Ro25-6981 (5.0 μg) impaired the acquisition of fear
memory induced by the single CS-US pairing protocol.
This result strongly suggests an essential role of NR2A-
NMDARs in the CA1 region in acquisition of contextual
fear memory, regardless of conditioning strength.
In summary, the present study strongly suggests an induc-
tion- and conditioning-protocol dependent involvement
of NR2B-NMDARs in the CA1 region in long-term poten-
tiation and contextual fear memory formation.
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